Article Information
History
- January 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Etienne Bastien, MSc1,
- Sophie Lefèvre-Arbogast, PhD2,3,
- Justine Lequesne, PhD3,*,
- François Gernier, MSc2,3,
- François Cherifi, MSc1,
- Olivier Rigal, MD4,5,
- Lydia Guittet, MD, PhD2,
- Jean-Michel Grellard, MSc3,
- Giulia Binarelli, MSc2,3,
- Marie Lange, PhD2,3,
- Marie Fernette3,
- Laure Tron, PhD2,
- Adeline Morel, MD1,
- Doriane Richard, PhD5,
- Bénédicte Griffon, PhD3,
- Alexandra Leconte, MSc3,
- Florian Quilan, MSc1,
- Louis-Ferdinand Pépin, MD5,
- Fabrice Jardin, MD, PhD5,6,
- Marianne Leheurteur, MD4,
- Audrey Faveyrial, MD1,
- Bénédicte Clarisse, PharmD, PhD3 and
- Florence Joly, MD, PhD1,2,3
- 1Medical Oncology Department, François Baclesse Center, Caen France
- 2Anticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen France
- 3Clinical Research, François Baclesse Center, Caen France
- 4Medical Oncology, Henri Becquerel Center, Rouen France
- 5Clinical Research, Henri Becquerel Center, Rouen France
- 6Hematology, Henri Becquerel Center, Rouen France
- ↵*Correspondence
Corresponding Author: Justine Lequesne, PhD, François Baclesse Center, 3 Avenue General Harris, 14076 Caen, France, j.lequesne{at}baclesse.unicancer.fr, Tel: 33 2 31 45 50 02, Fax: 33 2 31 45 51 58